Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 2/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.77 |
| ▸ | KCNK5 | O95279 | 1/20 | 0.49 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.49 |
| ▸ | KCNK17 | Q96T54 | 1/20 | 0.49 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29778218 | 0.87 | KCNK3 (1.00) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL498292 | 0.87 | KCNK3 (1.00) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL12434086 | 0.80 | KCNK3 (0.84) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL726080 | 0.77 | KCNA5 (0.77) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL12434102 | 0.77 | KCNK3 (0.81) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL12434454 | 0.76 | KCNK3 (0.81) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL16250691 | 0.74 | NPC1 (0.62) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL2634370 | 0.72 | KCNK3 (0.66) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL12434083 | 0.71 | KCNK3 (0.73) | KCNK3KCNH2KCNK5KCNA5KCNK17 | |
| SCHEMBL12434461 | 0.71 | KCNK3 (0.72) | KCNK3KCNH2KCNK5KCNA5KCNK17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438045-B1 | CRYSTALLINE PHASES OF 2'-{[2-(4-METHOXY-PHENYL)-ACETYLAMINO]-METHYL}-BIPHENYL-2-CARBOXYLIC ACID (2-PYRIDIN-3-YL-ETHYL)-AMIDE | SANOFI AVENTIS DEUTSCHLAND (DE) | 2016-10-05 | — | — | EP | claimed |
| JP-4658919-B2 | — | — | 2011-03-23 | — | — | JP | claimed |
| EP-1605976-B1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-02-24 | — | — | EP | claimed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | claimed |
| JP-2006520342-A | — | — | 2006-09-07 | — | — | JP | claimed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | claimed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | claimed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | claimed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | claimed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | claimed |
| EP-1605976-B1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-02-24 | — | — | EP | disclosed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | disclosed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | disclosed |